PMC:7555630 / 1508-2681 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":485,"end":489},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"Coronavirus disease 2019 (COVID-19) is a novel respiratory illness first reported in December 2019 [1]. The manifestations of COVID-19 may range from mild (or asymptomatic) to severe illness leading to respiratory failure and death [2]. The current literature suggests that the factors associated with worse outcomes include older age (\u003e50 years), male sex, living in long-term care facilities, and medical comorbidities such as cardiovascular disease, hypertension, diabetes, chronic lung disease, renal disease, and immunosuppression [3,4]. Parkinson disease (PD) and other movement disorders have not been reported as particular risk factors for more serious sequelae from COVID-19 to date. However, because the patients cared for at specialized Movement Disorders programs are frequently older, tend to have an increased incidence of physical comorbidities (including identified risk factors for more severe manifestations of COVID-19), have increased frailty, and are more likely to be residents of long-term care facilities [5,6,7,8,9], concerns were raised early in the pandemic that this patient population may be particularly vulnerable to the disease [5,6,10,11]."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":485,"end":489},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Coronavirus disease 2019 (COVID-19) is a novel respiratory illness first reported in December 2019 [1]. The manifestations of COVID-19 may range from mild (or asymptomatic) to severe illness leading to respiratory failure and death [2]. The current literature suggests that the factors associated with worse outcomes include older age (\u003e50 years), male sex, living in long-term care facilities, and medical comorbidities such as cardiovascular disease, hypertension, diabetes, chronic lung disease, renal disease, and immunosuppression [3,4]. Parkinson disease (PD) and other movement disorders have not been reported as particular risk factors for more serious sequelae from COVID-19 to date. However, because the patients cared for at specialized Movement Disorders programs are frequently older, tend to have an increased incidence of physical comorbidities (including identified risk factors for more severe manifestations of COVID-19), have increased frailty, and are more likely to be residents of long-term care facilities [5,6,7,8,9], concerns were raised early in the pandemic that this patient population may be particularly vulnerable to the disease [5,6,10,11]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T16","span":{"begin":0,"end":24},"obj":"Disease"},{"id":"T17","span":{"begin":26,"end":34},"obj":"Disease"},{"id":"T18","span":{"begin":126,"end":134},"obj":"Disease"},{"id":"T19","span":{"begin":202,"end":221},"obj":"Disease"},{"id":"T20","span":{"begin":429,"end":451},"obj":"Disease"},{"id":"T21","span":{"begin":453,"end":465},"obj":"Disease"},{"id":"T22","span":{"begin":467,"end":475},"obj":"Disease"},{"id":"T23","span":{"begin":485,"end":497},"obj":"Disease"},{"id":"T24","span":{"begin":499,"end":512},"obj":"Disease"},{"id":"T26","span":{"begin":543,"end":560},"obj":"Disease"},{"id":"T27","span":{"begin":562,"end":564},"obj":"Disease"},{"id":"T28","span":{"begin":576,"end":594},"obj":"Disease"},{"id":"T29","span":{"begin":676,"end":684},"obj":"Disease"},{"id":"T30","span":{"begin":749,"end":767},"obj":"Disease"},{"id":"T31","span":{"begin":930,"end":938},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0021113"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0004995"},{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0005275"},{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0002118"},{"id":"A25","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0005240"},{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0005180"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0005180"},{"id":"A28","pred":"mondo_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/MONDO_0005395"},{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0005395"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Coronavirus disease 2019 (COVID-19) is a novel respiratory illness first reported in December 2019 [1]. The manifestations of COVID-19 may range from mild (or asymptomatic) to severe illness leading to respiratory failure and death [2]. The current literature suggests that the factors associated with worse outcomes include older age (\u003e50 years), male sex, living in long-term care facilities, and medical comorbidities such as cardiovascular disease, hypertension, diabetes, chronic lung disease, renal disease, and immunosuppression [3,4]. Parkinson disease (PD) and other movement disorders have not been reported as particular risk factors for more serious sequelae from COVID-19 to date. However, because the patients cared for at specialized Movement Disorders programs are frequently older, tend to have an increased incidence of physical comorbidities (including identified risk factors for more severe manifestations of COVID-19), have increased frailty, and are more likely to be residents of long-term care facilities [5,6,7,8,9], concerns were raised early in the pandemic that this patient population may be particularly vulnerable to the disease [5,6,10,11]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T5","span":{"begin":39,"end":40},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T6","span":{"begin":348,"end":352},"obj":"http://purl.obolibrary.org/obo/UBERON_0003101"},{"id":"T7","span":{"begin":348,"end":352},"obj":"http://www.ebi.ac.uk/efo/EFO_0000970"},{"id":"T8","span":{"begin":485,"end":489},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T9","span":{"begin":485,"end":489},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"Coronavirus disease 2019 (COVID-19) is a novel respiratory illness first reported in December 2019 [1]. The manifestations of COVID-19 may range from mild (or asymptomatic) to severe illness leading to respiratory failure and death [2]. The current literature suggests that the factors associated with worse outcomes include older age (\u003e50 years), male sex, living in long-term care facilities, and medical comorbidities such as cardiovascular disease, hypertension, diabetes, chronic lung disease, renal disease, and immunosuppression [3,4]. Parkinson disease (PD) and other movement disorders have not been reported as particular risk factors for more serious sequelae from COVID-19 to date. However, because the patients cared for at specialized Movement Disorders programs are frequently older, tend to have an increased incidence of physical comorbidities (including identified risk factors for more severe manifestations of COVID-19), have increased frailty, and are more likely to be residents of long-term care facilities [5,6,7,8,9], concerns were raised early in the pandemic that this patient population may be particularly vulnerable to the disease [5,6,10,11]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":348,"end":352},"obj":"Chemical"},{"id":"T2","span":{"begin":562,"end":564},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_30780"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_74756"}],"text":"Coronavirus disease 2019 (COVID-19) is a novel respiratory illness first reported in December 2019 [1]. The manifestations of COVID-19 may range from mild (or asymptomatic) to severe illness leading to respiratory failure and death [2]. The current literature suggests that the factors associated with worse outcomes include older age (\u003e50 years), male sex, living in long-term care facilities, and medical comorbidities such as cardiovascular disease, hypertension, diabetes, chronic lung disease, renal disease, and immunosuppression [3,4]. Parkinson disease (PD) and other movement disorders have not been reported as particular risk factors for more serious sequelae from COVID-19 to date. However, because the patients cared for at specialized Movement Disorders programs are frequently older, tend to have an increased incidence of physical comorbidities (including identified risk factors for more severe manifestations of COVID-19), have increased frailty, and are more likely to be residents of long-term care facilities [5,6,7,8,9], concerns were raised early in the pandemic that this patient population may be particularly vulnerable to the disease [5,6,10,11]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T11","span":{"begin":47,"end":66},"obj":"Phenotype"},{"id":"T12","span":{"begin":202,"end":221},"obj":"Phenotype"},{"id":"T13","span":{"begin":429,"end":451},"obj":"Phenotype"},{"id":"T14","span":{"begin":453,"end":465},"obj":"Phenotype"},{"id":"T15","span":{"begin":477,"end":497},"obj":"Phenotype"},{"id":"T16","span":{"begin":543,"end":552},"obj":"Phenotype"},{"id":"T17","span":{"begin":576,"end":594},"obj":"Phenotype"},{"id":"T18","span":{"begin":749,"end":767},"obj":"Phenotype"}],"attributes":[{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0002086"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0002878"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0001626"},{"id":"A14","pred":"hp_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/HP_0000822"},{"id":"A15","pred":"hp_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/HP_0006528"},{"id":"A16","pred":"hp_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/HP_0001300"},{"id":"A17","pred":"hp_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/HP_0100022"},{"id":"A18","pred":"hp_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/HP_0100022"}],"text":"Coronavirus disease 2019 (COVID-19) is a novel respiratory illness first reported in December 2019 [1]. The manifestations of COVID-19 may range from mild (or asymptomatic) to severe illness leading to respiratory failure and death [2]. The current literature suggests that the factors associated with worse outcomes include older age (\u003e50 years), male sex, living in long-term care facilities, and medical comorbidities such as cardiovascular disease, hypertension, diabetes, chronic lung disease, renal disease, and immunosuppression [3,4]. Parkinson disease (PD) and other movement disorders have not been reported as particular risk factors for more serious sequelae from COVID-19 to date. However, because the patients cared for at specialized Movement Disorders programs are frequently older, tend to have an increased incidence of physical comorbidities (including identified risk factors for more severe manifestations of COVID-19), have increased frailty, and are more likely to be residents of long-term care facilities [5,6,7,8,9], concerns were raised early in the pandemic that this patient population may be particularly vulnerable to the disease [5,6,10,11]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T13","span":{"begin":0,"end":103},"obj":"Sentence"},{"id":"T14","span":{"begin":104,"end":236},"obj":"Sentence"},{"id":"T15","span":{"begin":237,"end":542},"obj":"Sentence"},{"id":"T16","span":{"begin":543,"end":693},"obj":"Sentence"},{"id":"T17","span":{"begin":694,"end":1173},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Coronavirus disease 2019 (COVID-19) is a novel respiratory illness first reported in December 2019 [1]. The manifestations of COVID-19 may range from mild (or asymptomatic) to severe illness leading to respiratory failure and death [2]. The current literature suggests that the factors associated with worse outcomes include older age (\u003e50 years), male sex, living in long-term care facilities, and medical comorbidities such as cardiovascular disease, hypertension, diabetes, chronic lung disease, renal disease, and immunosuppression [3,4]. Parkinson disease (PD) and other movement disorders have not been reported as particular risk factors for more serious sequelae from COVID-19 to date. However, because the patients cared for at specialized Movement Disorders programs are frequently older, tend to have an increased incidence of physical comorbidities (including identified risk factors for more severe manifestations of COVID-19), have increased frailty, and are more likely to be residents of long-term care facilities [5,6,7,8,9], concerns were raised early in the pandemic that this patient population may be particularly vulnerable to the disease [5,6,10,11]."}

{"project":"2_test","denotations":[{"id":"32962001-31986264-44895993","span":{"begin":100,"end":101},"obj":"31986264"},{"id":"32962001-32109013-44895994","span":{"begin":233,"end":234},"obj":"32109013"},{"id":"32962001-32171076-44895995","span":{"begin":537,"end":538},"obj":"32171076"},{"id":"32962001-32444366-44895996","span":{"begin":539,"end":540},"obj":"32444366"},{"id":"32962001-32250324-44895997","span":{"begin":1033,"end":1034},"obj":"32250324"},{"id":"32962001-32344993-44895998","span":{"begin":1035,"end":1036},"obj":"32344993"},{"id":"32962001-32741841-44895999","span":{"begin":1039,"end":1040},"obj":"32741841"},{"id":"32962001-32250324-44896000","span":{"begin":1164,"end":1165},"obj":"32250324"},{"id":"32962001-32291797-44896001","span":{"begin":1166,"end":1168},"obj":"32291797"},{"id":"32962001-32390643-44896002","span":{"begin":1169,"end":1171},"obj":"32390643"}],"text":"Coronavirus disease 2019 (COVID-19) is a novel respiratory illness first reported in December 2019 [1]. The manifestations of COVID-19 may range from mild (or asymptomatic) to severe illness leading to respiratory failure and death [2]. The current literature suggests that the factors associated with worse outcomes include older age (\u003e50 years), male sex, living in long-term care facilities, and medical comorbidities such as cardiovascular disease, hypertension, diabetes, chronic lung disease, renal disease, and immunosuppression [3,4]. Parkinson disease (PD) and other movement disorders have not been reported as particular risk factors for more serious sequelae from COVID-19 to date. However, because the patients cared for at specialized Movement Disorders programs are frequently older, tend to have an increased incidence of physical comorbidities (including identified risk factors for more severe manifestations of COVID-19), have increased frailty, and are more likely to be residents of long-term care facilities [5,6,7,8,9], concerns were raised early in the pandemic that this patient population may be particularly vulnerable to the disease [5,6,10,11]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"75","span":{"begin":715,"end":723},"obj":"Species"},{"id":"76","span":{"begin":1096,"end":1103},"obj":"Species"},{"id":"77","span":{"begin":0,"end":24},"obj":"Disease"},{"id":"78","span":{"begin":26,"end":34},"obj":"Disease"},{"id":"79","span":{"begin":47,"end":66},"obj":"Disease"},{"id":"80","span":{"begin":126,"end":134},"obj":"Disease"},{"id":"81","span":{"begin":202,"end":221},"obj":"Disease"},{"id":"82","span":{"begin":226,"end":231},"obj":"Disease"},{"id":"83","span":{"begin":429,"end":451},"obj":"Disease"},{"id":"84","span":{"begin":453,"end":465},"obj":"Disease"},{"id":"85","span":{"begin":467,"end":475},"obj":"Disease"},{"id":"86","span":{"begin":485,"end":497},"obj":"Disease"},{"id":"87","span":{"begin":499,"end":512},"obj":"Disease"},{"id":"88","span":{"begin":543,"end":560},"obj":"Disease"},{"id":"89","span":{"begin":562,"end":564},"obj":"Disease"},{"id":"90","span":{"begin":576,"end":594},"obj":"Disease"},{"id":"91","span":{"begin":676,"end":684},"obj":"Disease"},{"id":"92","span":{"begin":749,"end":767},"obj":"Disease"},{"id":"93","span":{"begin":930,"end":938},"obj":"Disease"}],"attributes":[{"id":"A75","pred":"tao:has_database_id","subj":"75","obj":"Tax:9606"},{"id":"A76","pred":"tao:has_database_id","subj":"76","obj":"Tax:9606"},{"id":"A77","pred":"tao:has_database_id","subj":"77","obj":"MESH:C000657245"},{"id":"A78","pred":"tao:has_database_id","subj":"78","obj":"MESH:C000657245"},{"id":"A79","pred":"tao:has_database_id","subj":"79","obj":"MESH:D012140"},{"id":"A80","pred":"tao:has_database_id","subj":"80","obj":"MESH:C000657245"},{"id":"A81","pred":"tao:has_database_id","subj":"81","obj":"MESH:D012131"},{"id":"A82","pred":"tao:has_database_id","subj":"82","obj":"MESH:D003643"},{"id":"A83","pred":"tao:has_database_id","subj":"83","obj":"MESH:D002318"},{"id":"A84","pred":"tao:has_database_id","subj":"84","obj":"MESH:D006973"},{"id":"A85","pred":"tao:has_database_id","subj":"85","obj":"MESH:D003920"},{"id":"A86","pred":"tao:has_database_id","subj":"86","obj":"MESH:D008171"},{"id":"A87","pred":"tao:has_database_id","subj":"87","obj":"MESH:D007674"},{"id":"A88","pred":"tao:has_database_id","subj":"88","obj":"MESH:D010300"},{"id":"A89","pred":"tao:has_database_id","subj":"89","obj":"MESH:D010300"},{"id":"A90","pred":"tao:has_database_id","subj":"90","obj":"MESH:D009069"},{"id":"A91","pred":"tao:has_database_id","subj":"91","obj":"MESH:C000657245"},{"id":"A92","pred":"tao:has_database_id","subj":"92","obj":"MESH:D009069"},{"id":"A93","pred":"tao:has_database_id","subj":"93","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Coronavirus disease 2019 (COVID-19) is a novel respiratory illness first reported in December 2019 [1]. The manifestations of COVID-19 may range from mild (or asymptomatic) to severe illness leading to respiratory failure and death [2]. The current literature suggests that the factors associated with worse outcomes include older age (\u003e50 years), male sex, living in long-term care facilities, and medical comorbidities such as cardiovascular disease, hypertension, diabetes, chronic lung disease, renal disease, and immunosuppression [3,4]. Parkinson disease (PD) and other movement disorders have not been reported as particular risk factors for more serious sequelae from COVID-19 to date. However, because the patients cared for at specialized Movement Disorders programs are frequently older, tend to have an increased incidence of physical comorbidities (including identified risk factors for more severe manifestations of COVID-19), have increased frailty, and are more likely to be residents of long-term care facilities [5,6,7,8,9], concerns were raised early in the pandemic that this patient population may be particularly vulnerable to the disease [5,6,10,11]."}